Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
01/06/2026 13:05
BRIEF-Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement June 1 (Reuters) - Rallybio Corp RLYB.O:
RALLYBIO CORPORATION AND AVENZO THERAPEUTICS ANNOUNCE MERGER AGREEMENT TO ADVANCE NEXT-GENERATION ONCOLOGY THERAPIES AND $215 MILLION CONCURRENT PRIVATE PLACEMENT
RALLYBIO - COMBINED COMPANY TO OPERATE AS AVENZO THERAPEUTICS, TRADE AS AVZO ON NASDAQ
RALLYBIO - PRE-DEAL RALLYBIO EQUITYHOLDERS TO OWN 2.8%, AVENZO EQUITYHOLDERS 97.2% OF COMBINED COMPANY
RALLYBIO - ATHENA COUNTOURIOTIS TO LEAD COMBINED COMPANY AS CHAIR, PRESIDENT AND CEO
Source text: ID:nBw8PBsQHa
Further company coverage: RLYB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx